Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1995
12/12/1995US5474993 7-oxo-6-amino-4-thia-1-azabicycl(3.2.0) heptanes; anticholesterol agents
12/12/1995US5474985 Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
12/12/1995US5474759 Non-chlorofluorocarbon aerosol formulations
12/12/1995CA2010692C Gelatin capsules containing ranitidine
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/11/1995CA2151113A1 Imidazolinyl tachykinin receptor antagonists
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/09/1995CA2150960A1 Use of n-[[5-(naphthalen-1-yl)-1,3-dioxan-2-yl]alkyl] -acetamide derivatives for the preparation of medicinal products which are useful in the treatment of neurodegenerative disorders
12/07/1995WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995WO1995033058A1 Gene coding for modified bone morphogenic protein receptor
12/07/1995WO1995032988A1 Novel parasite protease genes and proteins
12/07/1995WO1995032987A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/07/1995WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
12/07/1995WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032967A1 Amide derivatives having 5ht1d-antagonist activity
12/07/1995WO1995032966A1 Indole derivatives as prodrugs of 5-ht1-like receptor agonists
12/07/1995WO1995032962A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995WO1995032961A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995WO1995032949A1 Gastrin and cck antagonists
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions
12/07/1995WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
12/07/1995WO1995032725A1 Angiotensin ii for improving fertilization
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995WO1995032710A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/07/1995WO1995032709A1 Activation of growth factors by matrix vesicles
12/07/1995WO1995030435A3 Compositions and treatment for multiple sclerosis
12/07/1995WO1995029165A3 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
12/07/1995DE4419315A1 New hetero- and oxo-pyrrolizine derivs.
12/07/1995DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
12/07/1995DE4419246A1 New hetero-aryl substd. pyrrolizine derivs.
12/07/1995CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof
12/07/1995CA2191576A1 Processes for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995CA2191575A1 A process for preparing 1-butyl-2-[2'-(2h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1h-indole-3-carboxylic acid
12/07/1995CA2191321A1 Gene coding for modified bone morphogenic protein receptor
12/07/1995CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells
12/07/1995CA2190870A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/07/1995CA2189741A1 Novel parasite protease genes and proteins
12/07/1995CA2187731A1 Activation of growth factors by matrix vesicles
12/06/1995EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate
12/06/1995EP0685476A1 Benzo(5,6)cycloheptapyridines, compositions and methods of use
12/06/1995EP0685475A1 Amino-benzofuryl-and thienyl-derivatives
12/06/1995EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives
12/06/1995EP0685473A2 Benzoheterocyclic compounds, as antioxidants
12/06/1995EP0685233A2 Thieno[1,5]benzodiazepine for treating gastrointestinal conditions
12/06/1995EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0684947A1 Amide compounds with pharmacological activity
12/06/1995EP0684945A1 Heterocyclic-substituted alkyl amide acat inhibitors
12/06/1995EP0684944A1 Coupling product obtained from hystamine and an amino acid
12/06/1995EP0684829A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof
12/06/1995EP0684827A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1$g(a),25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
12/06/1995EP0684764A1 Treatment of androgen-associated baldness using antisense oligomers
12/06/1995EP0593478B1 Leukotriene b 4 antagonists
12/06/1995EP0588850B1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/06/1995EP0544819B1 Indole derivatives which inhibit leukotriene biosynthesis
12/06/1995EP0495106B1 Osteogenesis promoter
12/06/1995CN1112920A Organopathy preventing, curing or ameliorating agent
12/06/1995CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound
12/06/1995CN1030452C Preparation of novel 2-aminopyrimidinone derivatives
12/05/1995US5473100 Hydroxamic acid derivative
12/05/1995US5473096 Substituted benzoate derivatives
12/05/1995US5473077 4-aminopyrrolidine-2,4-substitude independently with carboxylic acid or 5-tetrazolyl for treating nervous system disorders and psychological disorders
12/05/1995US5473067 For controlling ocular hypertension
12/05/1995US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/05/1995US5472979 1,2,3,4-tetrahydronaphthalene compounds
12/05/1995US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
12/05/1995US5472961 Acetamides
12/05/1995US5472959 Hypotensive agents, congestive heart failure
12/05/1995US5472943 Co-administering agonist and antagonist
12/05/1995US5472857 DNA encoding canine granulocyte colony stimulating factor (G-CSF)
12/04/1995CA2150517A1 Thieno ¬1,5| benzodiazepine use
12/01/1995CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives
12/01/1995CA2150300A1 Amino-benzofuryl- and thienyl-derivatives
11/1995
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032209A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT3 ANTAGONISTS
11/30/1995WO1995032208A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
11/30/1995WO1995032204A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995WO1995032203A2 Use of tetrahydropteridine derivatives as no-synthase inhibitors
11/30/1995WO1995032198A1 Imidazole derivatives and processes for the preparation thereof
11/30/1995WO1995032197A1 Palladium catalyzed ring closure of triazolyl tryptamine
11/30/1995WO1995032196A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995WO1995032194A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995WO1995032191A1 Inhibitors of farnesyl-protein transferase
11/30/1995WO1995032190A2 Pharmaceutical diketopiperazine compounds
11/30/1995WO1995032185A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031977A1 Novel potent inducers of terminal differentiation and methods of use thereof
11/30/1995DE4418097A1 Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase Using Tetrahydropteridin derivatives as inhibitors of NO synthase
11/30/1995CA2190846A1 Inhibitors of farnesyl-protein transferase
11/30/1995CA2190501A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995CA2190472A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
11/30/1995CA2190468A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995CA2190279A1 Pharmaceutical diketopiperazine compounds
1 ... 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 ... 1564